Renal Cancer Clinical Trials

38 recruiting

Renal Cancer Trials at a Glance

48 actively recruiting trials for renal cancer are listed on ClinicalTrialsFinder across 6 cities in 22 countries. The largest study group is Not Applicable with 16 trials, with the heaviest enrollment activity in New York, London, and Boston. Lead sponsors running renal cancer studies include National Cancer Institute (NCI), Peking University First Hospital, and IRCCS Azienda Ospedaliero-Universitaria di Bologna.

Browse renal cancer trials by phase

Treatments under study

About Renal Cancer Clinical Trials

Looking for clinical trials for Renal Cancer? There are currently 38 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Renal Cancer trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Renal Cancer clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 48 trials

Recruiting

Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease

Bladder CancerKidney CancerRenal Cancer+2 more
National Cancer Institute (NCI)5,950 enrolled1 locationNCT00026884
Recruiting

Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies

SarcomaEndocrine TumorsNeuroblastoma+2 more
National Cancer Institute (NCI)6,035 enrolled5 locationsNCT01109394
Recruiting
Phase 1Phase 2

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Metastatic Renal Cell CarcinomaCarcinoma, Renal CellAdvanced Renal Cell Carcinoma+8 more
Pfizer224 enrolled49 locationsNCT07227415
Recruiting
Not Applicable

CAIX PET/ CT Guided Radiation Therapy in CcRCC.

Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital70 enrolled1 locationNCT07540260
Recruiting

Kidney Cancer DNA Registry

Renal Cancer
Memorial Sloan Kettering Cancer Center750 enrolled7 locationsNCT02087852
Recruiting
Phase 2

Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus

Renal Cell CarcinomaKidney CancerRenal Cancer+1 more
University of Colorado, Denver17 enrolled3 locationsNCT05969496
Recruiting

Von Hippel-Lindau (VHL): Clinical Manifestations, Diagnosis, Management and Molecular Bases of Inherited Renal and Other Urologic Malignant Disorders

Renal Cell CarcinomaKidney CancerClear Cell Renal Cancer+2 more
National Cancer Institute (NCI)5,000 enrolled1 locationNCT00001238
Recruiting
Phase 2

A Study of Sasanlimab, Palbociclib and Axitinib in Metastatic Renal Cell Carcinoma

Metastatic Renal Cell CarcinomaRenal Cell CarcinomaKidney Cancer+3 more
Stephanie Berg25 enrolled2 locationsNCT07123090
Recruiting
Phase 1Phase 2

64Cu-GRIP B in Patients With Advanced Malignancies

Prostate CancerAdvanced Solid TumorSolid Tumor, Adult+3 more
Rahul Aggarwal91 enrolled1 locationNCT05888532
Recruiting
Not Applicable

68Ga-PSMA PET in the Renal Cell Carcinoma

MetastasesRenal CancerPSMA PET
Xijing Hospital300 enrolled9 locationsNCT04987086
Recruiting

Occupational Situation and Return to Work of Urological Patients

Prostate CancerBladder CancerRenal Cancer+1 more
Jagiellonian University2,000 enrolled1 locationNCT07088536
Recruiting
Phase 1

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

Advanced Solid TumorMesotheliomaRenal Cancer+3 more
Nuvectis Pharma, Inc.140 enrolled12 locationsNCT05873686
Recruiting

A Study of Ward Admissions for Haematuria

Urothelial CarcinomaBladder CancerRenal Cancer+3 more
British Urology Researchers in Surgical Training1,050 enrolled1 locationNCT07395037
Recruiting
Phase 3

Spinal Morphine or Intravenous Lidocaine in Robot-assisted Upper Urologic Surgery

Ureter CancerRenal CancerOther Specified Disorders of Kidney and Ureter+5 more
Hans Bahlmann220 enrolled3 locationsNCT06349668
Recruiting

SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer

Metastatic Renal CancerRadiation TherapyRecurrent Renal Cell Cancer
Peking University First Hospital300 enrolled2 locationsNCT06583070
Recruiting

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

Colon CancerMultiple MyelomaLymphoma+2 more
Memorial Sloan Kettering Cancer Center500 enrolled6 locationsNCT00582621
Recruiting

Prospective Observational Trial of Image-guided Ablative STereotactic bOdy Radiation Therapy for Primary kidNey Cancer: the STONE Trial

Renal Cancer
Istituto Clinico Humanitas53 enrolled2 locationsNCT07299357
Recruiting

Intra-procedural Spectral CT for Image-guided Embolization and Ablation in Interventional Oncology

Renal CancerLiver Cancer (Primary and Metastatic)
Palo Alto Veterans Institute for Research30 enrolled1 locationNCT07303725
Recruiting
Not Applicable

Decision Aid (DA) for Renal Patients

Renal CancerKidney Tumor
NYU Langone Health40 enrolled1 locationNCT05387863
Recruiting

Women With isoLated acUte cyStitis and Macroscopic Hematuria. Is Further Investigation Needed?

Urothelial CarcinomaBladder CancerRenal Cancer+2 more
Vastra Gotaland Region300 enrolled1 locationNCT07037589